ORAL FORMULATIONS OF S(+)-ETODOLAC

摘要

This invention discloses organoleptically acceptable formulations containing S(+) 1,8-diethyl-1,3,4,9-tetrahydropyranoÄ3,4-bÜindole-1-acetic acid, preferably with an acidic component, also known as S(+)etodolic acid or S(+)etodolac.